MODULATORISCHE POLYNUKLEOTIDE

European patent · EP3458588 · In force

Register entry

Publication number
EP3458588
Application number
EP17800147
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 18, 2017
Published
Mar 27, 2019
Granted
Oct 29, 2025
Protection ends at the latest
May 17, 2037
Next annual fee due
May 31, 2027
IPC classes
C12N 15/113 (2010.01)
C12N 15/85 (2006.01)
Priority
US 201662338137 P 18.05.2016
US 201762485050 P 13.04.2017
PCT application
PCT/US2017/033268 18.05.2017
PCT publication
WO2017/201248 23.11.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 9, 2026

    Change

    Published in Swissreg on 09.09.2026

  2. Jun 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.05.2026 → 31.05.2027

    Published in Swissreg on 01.06.2026

  3. Jan 26, 2026

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 26.01.2026

  4. Oct 29, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.10.2025

Parties

Holder

Voyager Therapeutics, Inc.

75 Hayden Ave., Lexington, Massachusetts 02421, US

Agent

Bovard AG

BOVARD AG

Optingenstrasse 16, 3013 Bern

Inventor

SAH, Dinah Wen-Yee

Cambridge Massachusetts 02139, US

HOU, Jinzhao

Cambridge Massachusetts 02139, US

NONNENMACHER, Mathieu

Cambridge Massachusetts 02139, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.